The mutationally activated Met receptor mediates motility and metastasis. - Wikidata - wikimedia - TriplyDB

The mutationally activated Met receptor mediates motility and metastasis.

The mutationally activated Met receptor mediates motility and metastasis.

http://www.wikidata.org/entity/Q36735738

about

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 The MET axis as a therapeutic target.Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy MET: a critical player in tumorigenesis and therapeutic target Exploration of molecular pathways mediating electric field-directed Schwann cell migration by RNA-seq.c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations Biology of MET: a double life between normal tissue repair and tumor progression HGF/SF-met signaling in the control of branching morphogenesis and invasion Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B MET receptor tyrosine kinase controls dendritic complexity, spine morphogenesis, and glutamatergic synapse maturation in the hippocampus The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.Host-pathogen systems biology: logical modelling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transduction Germline met mutations in mice reveal mutation- and background-associated differences in tumor profiles.MET and MYC cooperate in mammary tumorigenesis.Mammary gland neoplasia: insights from transgenic mouse models.The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.Metastasis of tumor cells is enhanced by downregulation of Bit1.Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model Transgenic mouse models of human breast cancer.A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.Development of c-MET pathway inhibitors.Mouse models of breast cancer metastasis.In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy.The role of the c-Met pathway in lung cancer and the potential for targeted therapy.c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma.Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia Targeting the HGF/c-MET pathway in hepatocellular carcinoma.Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.Association Analysis of MET Gene Polymorphism with Papillary Thyroid Carcinoma in a Chinese Population.The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells From Tpr-Met to Met, tumorigenesis and tubes.Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53

P2860

Q24541450-41646788-182F-437B-90FA-8CB1894CFB3E Q24609682-C5D20C69-C730-48B5-A92F-C2ACF305CACD Q24629814-B323FF71-17FE-464B-BEA8-BAF833A1BF4F Q24681561-8F6C0352-A8DC-4CA4-A5C0-09DE81025D84 Q27008925-55A71023-28BB-4BEF-B677-5859F3FF25EA Q27334371-65BFB9F6-3A75-4288-B736-9FBF3BAD7CB3 Q27649203-1EC4997E-5DCB-4F23-93EC-87351FFCB080 Q28085247-CA5FDAD5-93F8-485E-A1DB-935338CCEF0B Q28202466-8E89F8FB-77DF-4E30-84AB-2D05ACF66E4D Q28216348-0D90CF79-B07F-4E54-8BD9-D94AB6240250 Q28216726-91AE58FE-5829-4B48-825D-1F24E7D0B71B Q28253238-4F6B408F-AE29-48F9-B0BF-49D7DDCFBA8D Q28254690-75057000-E214-4C9A-AA1E-E15357C1E9E1 Q28345285-7273DBBF-073F-4898-8894-427B7EEC6628 Q30446159-F5916AF4-2F6A-4627-A5F7-66796CBEE5D9 Q30668977-F3868071-2240-4D9D-A85E-6AEBAA3D99A1 Q33314672-6EF43468-2CCE-4BFD-BB2C-07419B332C64 Q33737789-D486DDC2-4DEF-4051-BB2F-2A778E07D6E5 Q33926873-D6A41AC5-D5C2-4E44-B053-19CCBFA1F8C9 Q33936692-19F38FBE-6C8C-46DA-A3FD-96C935BE8611 Q33959078-A730A973-714E-480D-8A35-ABE19F6AED56 Q33969327-80038FC9-EE75-4E4D-9527-94655ED74383 Q34008985-8DC84B7A-97C2-4BAC-A8FA-F86FDF5F4533 Q34099443-A9285D1D-201B-424B-BC92-59C2DB4F7EA5 Q34130558-F87E6E76-4DD3-44D8-856D-F2FA76B98824 Q34185858-4D8EED53-CCC9-422D-BC2F-319EABD866B4 Q34198905-E6FAEFE9-D20F-4E57-839F-321E9B732015 Q34553964-35211162-9A14-4500-9898-E1631EB866B3 Q35070072-C5C546F6-3033-4EC7-8A80-DE75548477A8 Q35094666-74EABF16-01FA-444A-9A6E-ECA851B287C2 Q35146937-21C78F2D-1153-4686-8F7A-9357C0786A3B Q35235798-977D9532-7670-4DC7-8582-A536D819129A Q35673676-BD06A951-F01A-4CD1-9E00-9E321F284E32 Q35861489-63772F31-006B-4A8D-9543-831C2E0A67A9 Q36093497-BAC0293B-2D2C-42CF-829D-44EE16A949A8 Q36326357-B344ADED-3A85-4B1C-A849-60A4E890F0BF Q36327886-857E2467-9189-48BE-8EA3-CC3EDB92B02B Q36407783-7EFBB13D-7463-4C22-B88C-82C68C0EF43F Q36745364-4E1E843C-48CD-40B4-A4A8-1FF140BF915A Q36957055-A2667798-2D19-467D-B8A4-8F297565FC37

P2860

The mutationally activated Met receptor mediates motility and metastasis.

http://www.wikidata.org/entity/Q36735738

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

The mutationally activated Met receptor mediates motility and metastasis.

@ast

The mutationally activated Met receptor mediates motility and metastasis.

@en

type

label

The mutationally activated Met receptor mediates motility and metastasis.

@ast

The mutationally activated Met receptor mediates motility and metastasis.

@en

prefLabel

The mutationally activated Met receptor mediates motility and metastasis.

@ast

The mutationally activated Met receptor mediates motility and metastasis.

@en

P1433

Q36735738-5CC90B38-16A2-4844-9702-5B9155427F33

P1476

Q36735738-8C195EBE-77B7-4FFD-8936-CC45A3C287E0

P2093

Q36735738-16EFDC6A-D511-46DA-A936-B4AA90F1DE67

Q36735738-AAC77FA6-8194-4723-9DFC-DA26E9A97678

Q36735738-AE3BF3FB-27C1-4439-9170-18BE2F32E93F

Q36735738-B12DFD49-CF46-44A1-AA01-C086AE4D17D1

Q36735738-E712EE51-E273-4501-8713-DCD266A887EA

Q36735738-F2048184-C2C4-4E12-A2BD-EE294F8E227C

P2860

Q36735738-03801EDD-F3CB-4AEC-8E3D-C6986620C354

Q36735738-0BC3C7E3-F648-42AF-B6DA-099333646EDA

Q36735738-11E1E35C-417E-41CB-A1E4-54FFCDC9DF21

Q36735738-18CE38F0-2A71-47E1-A033-A54C881D69F6

Q36735738-1AB94A08-0A6B-4C11-84FF-88FAAF3001FB

Q36735738-3AB0917A-263C-461D-AA88-C6CFD09898ED

Q36735738-3B185BC1-213E-4A30-8C77-752AFB255383

Q36735738-426CF7C3-B7EB-4197-8C1B-0BA1018DB8C4

Q36735738-4DC3082F-87AC-4685-8BF2-0E9FB2B58C2F

Q36735738-5CAD7FA8-68E8-4A4D-AED1-0F367E12E470

P304

Q36735738-EB1C9828-9632-4C93-A178-0A0B2B7AC6A5

P31

Q36735738-6891450A-1E63-4DB0-868B-542C37F29A54

P356

Q36735738-191B1EA8-3184-4C0A-AF92-6FBE91D11E3C

P407

Q36735738-1666C265-6F37-4BAF-A4A8-CC1A6637892F

P433

Q36735738-245B11BF-9E18-41B3-ADC0-57A820F83561

P478

Q36735738-D1C50DA9-D7F3-4432-8112-8F7BEF375719

P577

Q36735738-BC3F934D-4131-46A0-8021-76A75B48F2BE

P5875

Q36735738-2666F100-A41B-4758-BD20-BD1177318006

P698

Q36735738-5DBEBEF5-8E8D-4EA5-B60C-8C9B730DE03E

P932

Q36735738-F4226C04-E9CF-4F44-AA1C-A40EE2BDA04F

P356

PNAS.95.24.14417

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The mutationally activated Met receptor mediates motility and metastasis.

@en

P2093

C P Webb

http://www.w3.org/2001/XMLSchema#string

G F Vande Woude

http://www.w3.org/2001/XMLSchema#string

M Anver

http://www.w3.org/2001/XMLSchema#string

M Fiscella

http://www.w3.org/2001/XMLSchema#string

M Jeffers

http://www.w3.org/2001/XMLSchema#string

S Koochekpour

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor

Regulation of cell motility by mitogen-activated protein kinase

Tumor cell interactions with the extracellular matrix during invasion and metastasis

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

Scatter factor/hepatocyte growth factor is essential for liver development

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter

Activation of the JNK pathway is essential for transformation by the Met oncogene

P304

14417-14422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.24.14417

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235614857

http://www.w3.org/2001/XMLSchema#string

P698

9826715

http://www.w3.org/2001/XMLSchema#string

P932

24388

http://www.w3.org/2001/XMLSchema#string